XL647
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for XL647, covering 2015-08-20 to 2022-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of XL647 in Subjects With Non-Small-Cell Lung Cancer [Phase 2]